PROFUND ADVISORS LLC

Position in ANAB — Anaptysbio, Inc

CIK 1129919 BETHESDA, MD

Position in ANAB

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$745,470

+$68,748 QoQ

Shares Held

11,044

-39.7% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#106

of 211 holders

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. ANAB ranks #74 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$745,470	11,044	-9.5%	Shares	Sole	2026-08-11
2026-03-31	$676,722	12,202	-6.8%	Shares	Sole	2026-04-27
2025-12-31	$634,506	13,088	+99.4%	Shares	Sole	2026-02-06
2025-09-30	$200,958	6,563	-51.4%	Shares	Sole	2025-11-06
2024-12-31	$178,687	13,496	+74.6%	Shares	Sole	2025-02-14
2024-09-30	$258,887	7,728	-16.1%	Shares	Sole	2024-11-14
2024-06-30	$230,803	9,210	-34.9%	Shares	Sole	2024-08-13
2024-03-31	$318,567	14,146	+33.1%	Shares	Sole	2024-05-08
2023-09-30	$190,950	10,632	-36.9%	Shares	Sole	2023-11-13
2023-06-30	$342,586	16,843	+16.5%	Shares	Sole	2023-08-10
2023-03-31	$314,715	14,463	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.